Corvus Pharmaceuticals, Inc.
Clinical trials sponsored by Corvus Pharmaceuticals, Inc., explained in plain language.
-
New pill shows promise in Hard-to-Treat blood cancer
Disease control Recruiting nowThis phase 3 trial tests a new oral drug, soquelitinib, against standard single-agent chemotherapy in 150 adults with relapsed or refractory peripheral T-cell lymphoma. The study aims to see if soquelitinib can delay cancer progression better than current options. Participants ar…
Phase: PHASE3 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New eczema pill shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis study tests a daily pill called soquelitinib in 200 adults with moderate to severe atopic dermatitis (eczema). Participants take either the drug or a placebo for 12 weeks, and doctors track skin improvements and side effects. The goal is to see if soquelitinib can safely red…
Phase: PHASE2 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC